glp 1 in obesity The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Treatment The GLP-1R plus strategy for
Description
The widespread use of these drugs for weight loss has sparked debates as to the medicalisation of obesity and the ethics of using pharmaceuticals for body modification (Arillotta et al., 2023)
[DOI] [PMC free article] [PubMed] [Google Scholar] 267.Wright J.W., Harding J.W
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Wright S.C., Motso A., Koutsilieri S., Beusch C.M., Sabatier P., Berghella A., et al
(4) bias in the measurement of the outcome
I pushed through and no longer have any side effects
